Effects of Motor Imagery Training on Gait and Brain Activation Pattern of Individuals With Parkinson's Disease
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03439800 |
Recruitment Status : Unknown
Verified February 2019 by Ana Raquel Rodrigues Lindquist, Universidade Federal do Rio Grande do Norte.
Recruitment status was: Recruiting
First Posted : February 20, 2018
Last Update Posted : February 6, 2019
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Primary Parkinsonism Rehabilitation Kinematics Gait Disorders, Neurologic | Other: Mental and Physical Practice Other: Physical Practice | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 66 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Double (Investigator, Outcomes Assessor) |
Primary Purpose: | Treatment |
Official Title: | Effects of Motor Imagery and Action Observation Training on Gait and Brain Activation Pattern of Individuals With Parkinson's Disease: Randomized Controlled Clinical Trial |
Actual Study Start Date : | February 15, 2018 |
Estimated Primary Completion Date : | August 2019 |
Estimated Study Completion Date : | December 2019 |

Arm | Intervention/treatment |
---|---|
Experimental: Mental and Physical Practice
Action observation: is defined as the observation of the motor action, in this study, through a video. Mental Practice: is defined as motor imagery training with the aim of improving the engine performance. Is the imagination of a motor action without its physical implementation. Physical Practice: is the execution of the motor action. |
Other: Mental and Physical Practice
|
Active Comparator: Physical Practice
Physical Practice: is the execution of the motor action.
|
Other: Physical Practice
|
- Velocity [ Time Frame: Change from Baseline Velocity at 1 day, 7 days and 30 days after training sessions ]Gait velocity in meters/second evaluated with Qualisys Motion Capture System
- Electroencephalographic activity [ Time Frame: Change from Baseline Electroencephalographic activity at 1 day, 7 days and 30 days after training sessions ]Sharpness of the mental image evaluated by the Emotiv Epoc +
- Mobility [ Time Frame: Change from Baseline Mobility at 1 day, 7 days and 30 days after training sessions ]Performance in the Timed Up and Go Test
- Stride length [ Time Frame: change from Baseline Stride length at 1 day, 7 days and 30 days after training sessions ]Stride length during gait of the most affected lower evaluated with Qualisys Motion Capture System

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 50 Years to 75 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Diagnosis of PD according to the report of a neurologist;
- Age between 50 and 75 years;
- In the moderate stage of the disease (between stages 2 and 3 of the Hoehn and Yahr Scale);
- Use of antiparkinsonian medication;
- Do not present cognitive deficits, according to the Mini Mental State Examination - MMSE. The cutoff point will be defined considering the individual's schooling (Illiterates: 18; With school instruction: 24);
- Ability to imagine motor acts in kinesthetic mode (according to the Revised Movement Imagery Questionnaire - MIQ-R). The cut-off point will be 20 for the kinesthetic modality, indicating that it is at least "a little easy to feel" the kinesthetically imagined movement;
- Have not undergone stereotaxic surgery.
Exclusion Criteria:
- Individuals with other associated neurological diseases;
- Individuals with musculoskeletal disorders, not related to the disease, but that impair gait;
- Individuals with hemodynamic instability before or during training;
- Individuals with uncorrected visual or auditory changes;
- Individuals who do not understand some stage of the training protocol.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03439800
Brazil | |
Lorenna Santiago | Recruiting |
Parnamirim, Rio Grande Do Norte, Brazil, 59148-520 | |
Contact: Lorenna Santiago +5584999029083 ext +5584999029083 lorennamms@gmail.com | |
Contact: Raquel Lindquist +5584981175502 ext +5584981175502 raquellindquist@ufrnet.br |
Responsible Party: | Ana Raquel Rodrigues Lindquist, PhD, Universidade Federal do Rio Grande do Norte |
ClinicalTrials.gov Identifier: | NCT03439800 |
Other Study ID Numbers: |
CEP-UFRN 2.057.658 |
First Posted: | February 20, 2018 Key Record Dates |
Last Update Posted: | February 6, 2019 |
Last Verified: | February 2019 |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Parkinson Disease Parkinsonian Disorders Nervous System Diseases Gait Disorders, Neurologic Basal Ganglia Diseases Brain Diseases |
Central Nervous System Diseases Movement Disorders Synucleinopathies Neurodegenerative Diseases Neurologic Manifestations |